309 related articles for article (PubMed ID: 14718322)
1. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
Fang MC; Stafford RS; Ruskin JN; Singer DE
Arch Intern Med; 2004 Jan; 164(1):55-60. PubMed ID: 14718322
[TBL] [Abstract][Full Text] [Related]
2. National patterns of warfarin use in atrial fibrillation.
Stafford RS; Singer DE
Arch Intern Med; 1996 Dec 9-23; 156(22):2537-41. PubMed ID: 8951296
[TBL] [Abstract][Full Text] [Related]
3. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
4. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
[TBL] [Abstract][Full Text] [Related]
5. Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996.
Stafford RS; Robson DC; Misra B; Ruskin J; Singer DE
Arch Intern Med; 1998 Oct; 158(19):2144-8. PubMed ID: 9801182
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
Hansen ML; Gadsbøll N; Gislason GH; Abildstrom SZ; Schramm TK; Folke F; Friberg J; Sørensen R; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
Europace; 2008 Apr; 10(4):395-402. PubMed ID: 18258807
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
8. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
9. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
[TBL] [Abstract][Full Text] [Related]
10. Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010.
Desai AM; Cavanaugh TM; Desai VC; Heaton PC; Kelton CM
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):539-47. PubMed ID: 24619888
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic treatment of atrial fibrillation].
Lelakowski J
Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of atrial fibrillation].
Gloor HO
Schweiz Med Wochenschr; 1996 Oct; 126(41):1739-47. PubMed ID: 8966506
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: current therapeutic approaches.
Deantonio HJ; Movahed A
Am Fam Physician; 1992 Jun; 45(6):2576-84. PubMed ID: 1350700
[TBL] [Abstract][Full Text] [Related]
14. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
15. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
17. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
[TBL] [Abstract][Full Text] [Related]
18. Trends in anticoagulation for atrial fibrillation in the U.S.: an analysis of the national ambulatory medical care survey database.
Rowan SB; Bailey DN; Bublitz CE; Anderson RJ
J Am Coll Cardiol; 2007 Apr; 49(14):1561-5. PubMed ID: 17418296
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.
Chandramouli BV; Kotler MN
Geriatrics; 1998 Jun; 53(6):46-8, 51-2, 54, 57-60. PubMed ID: 9634106
[TBL] [Abstract][Full Text] [Related]
20. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
